DiaSorin S.p.A. (DIA.MI)

94,94 -1,30 (-1,35%) Börsenschluss: 05:35PM CEST

DiaSorin S.p.A.

Via Crescentino
Saluggia, VC 13040
Italy
39 01 614871
https://diasoringroup.com/en

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 3.184

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Carlo Rosa	CEO, GM & Executive Director	1,75M	N/A	1966
Dr. Chen Menachem Even	Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director	857,25k	N/A	1963
Mr. Piergiorgio Pedron	Senior Corporate VP, CFO & Corporate Accounting Documents Officer	N/A	N/A	1971
Mr. Fabrizio Piercarlo Bonelli	Corporate VP & Chief Technology Officer	N/A	N/A	N/A
Dr. Riccardo Fava	Corporate Vice President of Communication, ESG & Investor Relations	N/A	N/A	N/A
Mr. Ulisse Spada	Corporate VP, Head of the Legal Department, Secretary & General Counsel	N/A	N/A	N/A
Mr. Stefano Ronchi	Senior Corporate Vice President of Human Resources	N/A	N/A	1960
Mr. Angelo Rago	President of Luminex Corporation	N/A	N/A	1963

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Corporate Governance

DiaSorin S.p.A.s ISS Governance QualityScore, Stand 29. April 2024, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 8, Shareholderrechte: 8, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.